Hallarsis, Bienvinido G.

HRN: 03-89-68  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2023
LEVOFLOXACIN 500MG (TAB)
10/08/2023
10/14/2023
PO
500mg
OD
COPD In AE CAP MR
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: